The LightPath® Imaging System is an intraoperative imaging device capable of rapidly acquiring molecular images of tissue specimens.

 

Features & Benefits

  • Rapid molecular imaging of surgical tissue specimens in the operating room
  • Imaging modalities include Cerenkov Luminescence Imaging and digital autoradiography
  • 3-5 minute scan time
  • Molecular specificity
  • Simple sample preparation
  • High spatial resolution
  • Compatible with all commercially-available PET imaging agents

Information

 

The LightPath® Imaging System has a CE Mark and is approved for sale in the European Union. The device has not received marketing authorization from the FDA.

 

Contact us for more information or to arrange a demo.

News

 
Lightpoint Medical awarded a three-year grant from Innovate UK
Apr 2, 2019
Molecular imaging emerges as a cancer surgery tool
Jan 21, 2019
Lightpoint Medical announces new office in Amsterdam
Jan 7, 2019